Background
==========

DNA methylation, a major epigenetic modification of the genome found in most eukaryotes, is essential for normal development and crucial in many biological processes, such as gene expression regulation, genomic imprinting, X-chromosome inactivation, suppression of repetitive elements, and carcinogenesis. DNA methylation preferentially occurs at the 5′ position of cytosine in CpG dinucleotides, which are mostly found in clusters known as CpG islands (CGIs) \[[@B1]\]. DNA methylation in the promoter or the first exon of a gene \[[@B2]\] generally leads to transcriptional silencing \[[@B3]\]. Profiling DNA methylation maps across the genome is important to understand DNA methylation changes that occur during development and in disease phenotypes. The genome-wide DNA methylation maps of many organisms, such as human \[[@B4]\], chicken \[[@B5],[@B6]\], rat \[[@B7]\], *Arabidopsis*\[[@B8]\], rice \[[@B9]\], and silkworm \[[@B10]\] has been reported. However, the methylation pattern of cattle remains unknown.

Somatic cell nuclear transfer (SCNT) (i.e., somatic cloning) is a promising technology with numerous potential applications, including reproduction of high-value domestic or endangered mammalians, biomedical research, human xenotransplantation, transgenic research, disease models, and therapeutic cloning. However, low cloning efficiency and a high incidence of developmental abnormalities in SCNT clones markedly hinder the use of this technology. Developmental abnormalities include the large offspring syndrome, respiratory problems, placental deficiency, obesity, prolonged gestation, short life span, fetal edema, dystocia, hydramnios, and perinatal death \[[@B11]-[@B13]\]. The developmental abnormalities in SCNT clones usually involve the placenta; the placenta is central to the onset of pathologies \[[@B11],[@B14]-[@B22]\], and most cloned fetuses die *in utero* because of placental deficiency \[[@B23]\]. We also found that placental weight and mean placentome weight were high, but the number of placentomes was low, in deceased cloned calves compared with calves produced by normal sexual reproduction \[[@B22]\]. The expression and DNA methylation levels of several imprinted genes were also aberrant in the placenta of deceased cloned calves \[[@B22]\]. Gene expression analyses of the placenta of cloned calves show that multiple pathways are affected \[[@B24],[@B25]\]. Placental abnormality may be the main cause of fetal death in clones. The principal cause of the developmental abnormalities of the fetus and placenta in cloned animals is aberrant epigenetic nuclear reprogramming of the donor somatic cell, which involves various epigenetic modifications. DNA methylation is a major epigenetic modification of the genome and is crucial in nuclear reprogramming during SCNT.

In this study, we analyzed the genome-wide DNA methylation pattern in the placentas of cattle with the use of methylated DNA immunoprecipitation combined with high-throughput sequencing (MeDIP-seq) by Illumina Genome Analyzer II. The DNA methylome distribution in the bovine genome was shown for the first time. Two placental tissues were used in this study, namely, the placental tissues of deceased cloned calves (SCNT) and normally produced calves (control).

Results
=======

Global mapping of DNA methylation in cattle
-------------------------------------------

To study the global mapping of DNA methylation in cattle, we generated a total of 8.1 Gb MeDIP-seq data from two placental samples, including 81,632,654 (SCNT) and 83,673,470 (control) raw reads. Of the total reads, 95.29% and 95.28% were mapped to the reference genome for the SCNT and control placentas, respectively, of which 42.18% and 42.87% were mapped to specific regions in the cattle genome (Table [1](#T1){ref-type="table"}).

###### 

Data generated by MeDIP-seq

  **Sample**   **Total number**   **Total mapped reads**   **Total unique mapped reads**   **Percentage of mapped**   **Percentage of unique mapped**
  ------------ ------------------ ------------------------ ------------------------------- -------------------------- ---------------------------------
  SCNT         81,632,654         77,789,461               32,812,637                      95.29%                     42.18%
  Control      83,673,470         79,723,259               34,179,701                      95.28%                     42.87%

MeDIP-seq reads were detected in most chromosomal regions (GGA1-29 and chromosome X) (Figure [1](#F1){ref-type="fig"}). Genome coverage was the percentage of bases mapped by genome-wide reads. In addition to CpG, 5-methylcytosine can also be found in several eukaryotic organisms in other sequence contexts, such as CHG and CHH (with H being A, C, or T), which are named as non-CG methylation. Therefore, we analyzed the genome coverage of the CG, CHG, and CHH sites under different sequencing depths (Additional file [1](#S1){ref-type="supplementary-material"}). Additional file [1](#S1){ref-type="supplementary-material"} shows that the genome coverage of the CG, CHG, and CHH sites negatively correlates with read depth; a large number of regions had low-depth coverage, and a small number of regions had high-depth coverage. Additional file [2](#S2){ref-type="supplementary-material"} shows the distribution of MeDIP-seq reads in different CG density regions.

![**Chromosome distribution of reads in the SCNT and control placentas.** The distribution of reads in chromosomes 1 to 29, and chromosome X of the cattle genome is shown in red for each sample. MeDIP-seq reads were plotted in 10 kb windows along the chromosome. **(A)**: SCNT placenta; **(B)**: control placenta.](1471-2164-15-12-1){#F1}

The read distribution on different genome regions represents the features of genome-wide methylation pattern. Analysis of the read distribution in different components of the genome showed that uniquely mapped reads were mainly present (approximately 27%) in intron regions (Additional file [3](#S3){ref-type="supplementary-material"}). The proportion of reads distinctly mapped to CGIs in the SCNT and control placentas was only 1.64% and 2.42%, respectively (Additional file [3](#S3){ref-type="supplementary-material"}). Many CpG islands were located in repetitive elements.

DNA methylation profile in bovine genes
---------------------------------------

The DNA methylation profile in the gene region was calculated by the reads that were aligned on a distinct locus in the genome. Generally, the DNA methylation level dramatically decreased in the 2 kb region upstream of the transcription start sites (TSSs) and dropped to the lowest point before the TSS. The DNA methylation level sharply increased in the 3′ direction and peaked just before the transcription termination site (TTS), and subsequently, the level dropped rapidly and remained constant at the middle level of DNA methylation after TTS (Figure [2](#F2){ref-type="fig"}). The DNA methylation level of the control placentas was higher than that of the SCNT placentas in the gene region. However, MeDIP-seq technology is dependent on high sequences, such that only regions of relatively high CpG abundance are obtained. Thus, many genes with spaced CpG sites may not be detected by MeDIP-seq, even if few CpG sites present are actually methylated.

![**DNA methylation distribution in the bovine gene region.** The DNA methylation profile in the gene region was shown by the reads that were aligned on the unique locus in the genome. The gene region was defined as the regions that contained a 2 kb region upstream of the TSS, the gene body from TSS to TTS, and a 2 kb region downstream of the TTS. In the upstream and downstream 2 kb regions, the regions were split into 20 non-overlapping windows, and the average alignment depth was calculated for each window. In the gene body, each gene was split into 40 equal windows, and the average alignment depth was calculated for each window. The y-axis is the average of the normalized depth for each window. The SCNT and control indicated the samples of placental tissues from cloned and normally produced cattle, respectively.](1471-2164-15-12-2){#F2}

Distribution of highly methylated regions
-----------------------------------------

The uniquely mapped reads were used to detect the highly methylated regions (HMRs), which are also called peaks. The HMR distribution in different genome regions was further analyzed. For the first time, we obtained 138,975 HMRs in the SCNT placenta (Additional file [4](#S4){ref-type="supplementary-material"}) and 145,218 HMRs in the control placenta (Additional file [5](#S5){ref-type="supplementary-material"}). The average length of HMRs was approximately 1,100 bp, and the HMR coverage on the genome was 5.86% to 5.89% (Table [2](#T2){ref-type="table"}). Additional file [6](#S6){ref-type="supplementary-material"} shows the CpG number in HMR. Most of the HMR have 5 to 25 CpG sites. Analysis of HMR distribution in the different components of the genome showed that the HMRs are mainly in the intron (approximately 27%) and the coding sequence (CDS; approximately 9%) regions (Figure [3](#F3){ref-type="fig"}). Analysis of HMR coverage in the different components showed that the genome coverage in 5′ UTR, CDS, 3′UTR, downstream 2 k, upstream 2 k, and intron was approximately 96%, 92%, 66%, 50%, 46%, and 10%, respectively (Additional file [7](#S7){ref-type="supplementary-material"}). Genome coverage was obtained as follows: (base number of HMRs in component/total base number of the component) × 100.

###### 

Information for HMRs

  **Sample**   **Total HMRs**   **HMR mean length**   **HMR total length**   **HMR covered size in genome (%)**
  ------------ ---------------- --------------------- ---------------------- ------------------------------------
  SCNT         138,975          1121.62               155,877,446            5.86
  Control      145,218          1080.16               156,859,286            5.89

![**HMR distribution in different components of the genome.** The y-axis is the number of HMR (peak). The x-axis shows the different components of the genome. **(A)**: SCNT placenta; **(B)**: control placenta.](1471-2164-15-12-3){#F3}

CpG islands in bovine placenta
------------------------------

In this study, CpG islands that overlapped with the HMRs were considered methylated CpG islands. For the first time, we identified a total of 37,191 CpG islands in cattle genome (Additional file [8](#S8){ref-type="supplementary-material"}). Of these CpG islands, only 14.68% (5,461) (Additional file [9](#S9){ref-type="supplementary-material"}), and 20.12% (7,482) (Additional file [10](#S10){ref-type="supplementary-material"}) were methylated in the SCNT and control placentas, respectively. These results indicated that most CpG islands were unmethylated in bovine placenta. Most of the methylated CpG islands were present in the introns and CDS regions (Table [3](#T3){ref-type="table"}).

###### 

Genomic distribution of methylated CpG islands

  **Sample**   **Total methylatied CGIs**   **Upstream 2 k**   **5′UTR**   **CDS**   **Intron**   **3′UTR**   **Downstream 2 k**   **Other**
  ------------ ---------------------------- ------------------ ----------- --------- ------------ ----------- -------------------- -----------
  SCNT         5461                         385                331         1,889     1,987        248         212                  409
  Control      7482                         534                445         2,699     2,844        366         313                  281

Methylated genes in bovine placenta
-----------------------------------

Methylated genes were defined in this study as genes overlapping (≥ 50%) with HMRs in the promoter or gene-body regions. A total of 7,974 methylated genes were found in the SCNT placenta, among which 302 genes were methylated only in promoters, 6,845 only in gene bodies, and 872 in both promoters and gene bodies (Additional file [11](#S11){ref-type="supplementary-material"}). A total of 8,466 methylated genes were found in the control placenta, among which 315 genes were methylated only in promoters, 7,212 only in gene bodies, and 939 in both promoters and gene bodies (Additional file [12](#S12){ref-type="supplementary-material"}).

MeDIP-seq data validation by bisulfite sequencing
-------------------------------------------------

We conducted bisulfite sequencing for nine selected gene regions on each unpooled samples. There were three individual samples in SCNT and control groups, respectively. The DNA methylation status of nine gene regions between SCNT and control groups were analyzed by one-way ANOVA and LSD tests using the SPSS 16.0 software. In MeDIP-seq results (Additional files [11](#S11){ref-type="supplementary-material"} and [12](#S12){ref-type="supplementary-material"}), upstream 2 k (promoter) of *IGF2* (NM_174087), *TCF7* (NM_001099186), and *UBE2S* (NM_001076472) were methylated in the control placentas, but unmethylated in SCNT placentas. Upstream 2 k of *SENP1* (NM_001206876), *ZNF3* (NM_001046614), *USP10* (NM_001098924), and *CD44* (NM_174013) were methylated in SCNT placentas, but unmethylated in control placentas. *CPT1B* (NM_001034349), not expressed in placenta, was hypermethylated in both SCNT and control placentas. The bisulfite sequencing results of the eight aforementioned gene regions were in accordance with the MeDIP-seq results (Additional file [13](#S13){ref-type="supplementary-material"}). The upstream 2 k of *HSP90AA1* (NM_001012670) was methylated in both SCNT and control placentas in MeDIP-seq results, contrary to the bisulfite sequencing results, which showed that the region was unmethylated in SCNT placentas. These validations were almost in accordance with the MeDIP-seq results (except one gene region in one sample), indicating the reliability of our methylation data obtained by MeDIP-seq.

DNA methylation and gene expression level
-----------------------------------------

We analyzed the gene expression in the placental tissues of deceased cloned calves (SCNT) and normally produced calves (control) using RNA-seq (Additional file [14](#S14){ref-type="supplementary-material"}). We categorized genes into five groups according to expression levels (Additional file [15](#S15){ref-type="supplementary-material"}): 0 (silent genes), 0--1 (lowly expressed genes), 1--20 (moderately expressed genes), 20--1000 (highly expressed genes), and \> 1000 (genes with the highest expression, housekeeping genes). The DNA methylation profile in and around gene bodies were compared among these five gene expression levels. A clearly negative and monotonic correlation was found between DNA methylation levels around the TSS of genes and gene expression levels. The TSS regions of highly expressed genes were relatively insufficiently DNA methylated, whereas the genes expressed at low levels were increasingly methylated (Figure [4](#F4){ref-type="fig"}). However, MeDIP-seq technology is dependent on high sequence. Thus, only regions with relatively high CpG abundance were obtained, and many genes with spaced CpG sites may not be detected.

![**DNA methylation levels around the TSS, gene body, and TTS across five gene expression level.** The DNA methylation profile in the gene region was shown by the reads that were aligned on a unique locus in the genome. The gene region referred to those regions in the 2 kb region upstream of the TSS, the gene body from TSS to TTS, and the 2 kb region downstream of the TTS. In upstream and downstream 2 kb regions, the regions were split into 20 non-overlapping windows, and the average alignment depth was calculated for each window. In the gene body, each gene was split into 40 equal windows, and the average alignment depth was calculated for each window. The Y-axis represents the average of the normalized depth for each window. Genes were divided into five groups according to expression levels: 0 (silent genes), 0--1 (low--level expressed genes), 1--20 (middle--level expressed genes), 20--1000 (high--level expressed genes), and \> 1000 (highest--level expressed genes, house-keeping genes). The DNA methylation profile in and around gene bodies were compared across these five gene expression levels. **(A)**: SCNT placenta; **(B)**: control placenta.](1471-2164-15-12-4){#F4}

However, the relationship between gene-body DNA methylation and expression levels shows a non-monotonic correlation (Figure [4](#F4){ref-type="fig"}). Moderately expressed genes generally have the highest levels of gene-body methylation, whereas the highly and lowly expressed genes, as well as the silent genes, show moderate DNA methylation levels. The housekeeping genes show the lowest DNA methylation levels.

In the downstream 2 kb regions of TSS, the silent genes and housekeeping genes show low DNA methylation levels, whereas moderately expressed genes also have the highest levels of gene-body methylation.

Online data deposition
----------------------

The MeDIP-seq and RNA-seq data from this study have been deposited in NCBI Sequence Read Archive with accession numbers SRP032370 and SRP033225, respectively, (<http://www.ncbi.nlm.nih.gov/sra/>).

Discussion
==========

Over the past decade, multiple methods have been developed and applied to analyze genome-wide DNA methylation profile, including MeDIP-seq, whole-genome bisulfite sequencing (WGBS), and reduced representation bisulfite sequencing (RRBS). WGBS is an excellent approach to determine the DNA methylome. The DNA methylome uses sodium bisulfite to convert unmethylated cytosine nucleotides to uracils and leaves methylated cytosines unmodified, which can be subsequently distinguished by sequencing. WGBS has high resolution, but it is costly, time consuming, involves complex data, and lacks comprehensive analytical tools, which considerably limit its popularity and applicability \[[@B26]\]. In MeDIP-seq, anti-5-methylcytosine antibody was first used to specifically recognize methylated cytosines, and the methylated DNA fragments were subsequently enriched. MeDIP-seq is a suitable method to analyze the DNA methylation status of heavily methylated genome regions. Many recent studies have shown that MeDIP-seq can reflect the relative genome-wide DNA methylation profile \[[@B5],[@B6],[@B27]\]. Therefore, we selected MeDIP-seq to analyze genome-wide profiles of DNA methylation in cattle in this study. However, MeDIP-seq technology is dependent on high sequence dependence. Thus, only regions of relatively high CpG abundance are obtained, and many genes with spaced CpG sites may not be detected. The methylation status of sequences where CpG sites are spaced (e.g., only one may occur in any given fragment) may appear unmethylated even if the few CpG sites present are actually methylated. Therefore, this method is no longer the technology of choice.

Genome-wide DNA methylation maps of many organisms have been reported, but the methylation pattern of cattle remains unknown. In this study, we report for the first time the genome-wide profiles of DNA methylation in the placentas of cattle. Cattle show analogous DNA methylation profiles to those of mammals and plants \[[@B4]-[@B6],[@B8]-[@B10]\]. In cattle, the DNA methylation level sharply decreased before the TSS, dramatically increased towards the 3′ direction, and stayed at a plateau until the 3′ end of the gene body.

In bovine placentas, the methylation levels in the gene body are relatively high, whereas the promoter (around TSSs) remains hypomethylated, a finding that is consistent in human \[[@B28]\] and chicken \[[@B5]\]. Most of the promoter regions were hypomethylated, and DNA methylation in the promoter repressed gene expression \[[@B29],[@B30]\]. Laurent et al. investigated the correlation of methylation profile with the expression level in human embryonic stem cells and found that the 20% of most highly expressed genes exhibited the lowest methylation levels at ±1 kb from the TSSs. The methylation levels increased. We also analyzed the relationship between DNA methylation and expression levels with decreasing gene expression. Consistent with previous reports in humans \[[@B28],[@B31],[@B32]\] and chicken \[[@B5]\], DNA methylation levels around TSSs at the 5′ ends of genes are negatively correlated with the gene expression level, a finding indicating that promoter methylation is a repressive epigenetic mark that downregulates gene expression. DNA methylation within gene bodies is more prevalent than in promoters, but information on the role of DNA methylation in gene bodies is insufficient. Gene-body methylation and expression levels apparently have a complex relationship. Gene-body DNA methylation is positively correlated with gene expression in humans \[[@B28],[@B31],[@B33]-[@B35]\]. However, the relationship between gene-body DNA methylation and gene expression levels is not monotonic but rather bell-shaped in plants, invertebrates, and even in humans; moderately expressed genes have the highest methylation levels \[[@B32],[@B36],[@B37]\]. In bovine placentas, moderately expressed genes have the highest degree of gene-body DNA methylation.

Aberrant epigenetic nuclear reprogramming during SCNT causes low cloning efficiency and developmental abnormalities in cloned animals. DNA methylation is a major epigenetic modification of the genome, and many studies have shown that abnormal DNA methylation reprogramming is found in cloned embryos and fetuses \[[@B11],[@B22],[@B38]-[@B41]\]. Chan et al. investigated genome-scale DNA methylation patterns of SCNT-reconstructed mouse embryos using RRBS for the first time and found that epigenetic reprogramming after nuclear transfer in SCNT mouse embryos does not fully recapitulate the natural DNA demethylation events that occur at fertilization, which results in aberrant methylation at some promoters and repetitive elements that may contribute to developmental failure \[[@B38]\]. Bovine SCNT blastocysts bear significantly higher methylation levels than *in vitro*-fertilized embryos at *satellite I* sequence \[[@B41]\]. In addition, the DNA methylation levels of several imprinted genes were found aberrant in various tissues of deceased SCNT calves \[[@B22],[@B40]\]. However, the genome-wide analysis of aberrant methylation in cloned animals has not been reported. In the present study, we screened out potentially aberrant methylated genes in the placentas of deceased cloned calves, which may have caused developmental abnormalities and ultimately resulted in the death of the cloned cattle. For example, *IGF2* was found hypomethylated in placentas of deceased SCNT calves but hypermethylated in those of normal calves in this study. The placenta-specific paternally expressed imprinted gene *IGF2*, which is a major modulator of placental and fetal growth \[[@B41]\], acts in the placenta to directly control the supply of maternal nutrients to the fetus. *IGF2* was overexpressed in cloned bovine embryos \[[@B42]\] and various tissues of deceased cloned calves \[[@B22],[@B40]\]. Yang and colleagues also found that *IGF2* was drastically over-expressed in the bladder, brain, heart, and lung of cloned calves suffering from the large offspring syndrome compared with normal controls \[[@B43]\]. *IGF2* expression was also aberrantly upregulated in the heart tissues of deceased cloned calves, and *IGF2* showed aberrant DNA methylation levels in the kidneys of deceased cloned calves \[[@B44]\]. In humans, *IGF2* upregulation is important in the pathogenesis of Beckwith-Wiedemann syndrome (BWS) \[[@B45]-[@B47]\], which is characterized by somatic overgrowth that is similar to the large offspring syndrome in ruminants. Based on these results, we inferred that hypomethylated *IGF2* and the upregulated *IGF2* expression may promote overall fetal growth, and thus can be related to the large offspring syndrome and death of cloned animals.

For the first time, we have completed the genome-wide mapping of DNA methylation in bovine placentas. This mapping can be used as a basis for further studies on epigenetic gene regulation in cattle and other ruminants.

Conclusions
===========

In this study, we have generated the genome-wide mapping of DNA methylation in cattle for the first time, and our results can be used for future studies on epigenetic gene regulation in cattle. This study contributes to the knowledge on epigenetics in cattle.

Methods
=======

Ethics statement
----------------

The entire experimental procedure was approved and supervised by the Animal Care Commission of the College of Veterinary Medicine, Northwest A&F University Shaanxi, China. The bovine ovaries used in this study were purchased from Tumen abattoir and Zhongle abattoir, two local slaughterhouses located in Xi'An, China. A 40-day-old female Holstein fetus was obtained for nuclear donor cell cultures, and Angus cows were used as recipients (Yangling Keyuan Cloning Co. Ltd).

Chemicals
---------

All chemicals and reagents were obtained from Sigma-Aldrich (St. Louis, USA), unless specifically stated otherwise. Disposable, sterile plasticware was obtained from Nunclon (Roskilde, Denmark).

Production of cloned calves and tissue collection
-------------------------------------------------

The production of cloned calves, including nuclear donor cell preparation, oocyte collection, and in vitro maturation, somatic cell nuclear transfer, activation, fusion, culture of cloned embryos, embryo transfer, and pregnancy diagnosis, were performed as previously described \[[@B48],[@B49]\]. Before SCNT, nuclear donor cells, which were established from the skin of the Holstein fetus, were cultured in serum-starved medium (0.5% fetal bovine serum, FBS) for 2 d. Cumulus--oocyte complexes (COCs) were matured *in vitro* for 20 h in bicarbonate-buffered tissue culture medium 199 (TCM-199, Gibco, USA) supplemented with 10% (v/v) FBS, 1 μg/mL 17 β-estradiol, and 0.075 IU/mL human menopausal gonadotropin. Oocytes with an extruded first polar body were selected and stained with 10 μg/mL Hoechst 33342 for 10 min prior to enucleation. A 20 μm inner diameter glass pipette was used to aspirate the first polar body and a small amount of surrounding cytoplasm. The expelled cytoplasm was surveyed under ultraviolet radiation to confirm the removal of nuclear material. With the use of the 20 μm inner diameter glass pipette, a single disaggregated donor cell was transferred to the pre-vitelline space of the enucleated oocytes. Oocyte-cell fusion was performed by a double electrical pulse of 35 V for 10 μs using a pair of platinum electrodes connected to a micromanipulator in microdrops of Zimmermann's fusion medium. The reconstructed cloned bovine embryos were activated in 5 μM ionomycin for 4 min, followed by treatment with 1.9 mM dimethynopyridine in synthetic oviductal fluid supplemented with amino acids and bovine serum albumin for 3 h to 4 h. The activated embryos were cultured in G1.5/G2.5 sequential media (Vitrolife AB, Gothenburg, Sweden) in a humidified atmosphere of 5% CO~2~ in air at 38.5°C. Fresh day 7 cloned blastocysts were non-surgically transferred (one embryo per recipient) to the synchronized recipient uterine horn ipsilateral to the corpus luteum 7 d after standing estrus. Eight cloned calves were delivered via C-section from days 286 to 290. Two cloned calves were stillborn, and the others died within 2 d after birth. The deceased calves suffered from placental abnormalities, including placental hypertrophy and a larger placentome, but a small number of placentomes were observed. We randomly selected placental tissues of three deceased cloned calves (SCNT samples) and three female Holstein calves produced by normal sexual reproduction (control samples) to perform genome-wide DNA methylation and RNA-seq analyses. After the birth of the calves, the fetal contributions of the placentas were immediately collected, rinsed thrice with RNA-free ddH~2~O and minced into pieces. The tissues were immediately frozen in liquid nitrogen and then stored at -80°C until DNA and RNA extractions.

DNA extraction and preparation for MeDIP-seq
--------------------------------------------

Genomic DNA was extracted from the placentas with the use of a TIANamp Genomic DNA Kit (Tiangen, Beijing, China), and DNA quality was evaluated by agarose gel electrophoresis and spectrophotometer. Additional file [16](#S16){ref-type="supplementary-material"} shows the preparation for MeDIP-seq. Genomic DNA isolated from the placentas of three randomly chosen deceased cloned calves (SCNT) were mixed in equal amounts to generate a pooled sample as SCNT. Genomic DNA isolated from the placentas of three female Holstein calves produced by normal sexual reproduction (control) were mixed in equal amounts to generate a pooled sample as control. In detail, DNA from each placenta was measured with Fluoroskan Ascent (Thermo Labsystems, Franklin, MA) and Picogreen reagents and kits (Molecular Probes, P-7589). The selected DNAs were diluted to a standard concentration. To ensure that the same amount of each DNA sample was transferred to the pool, Hamilton ML2200 and Vivace automated pipetting stations were used to transfer each DNA sample into a single tube. Then, the pool sample was gently mixed and requantified before further dilution to a working concentration. Subsequently, these two pooled samples were sonicated to produce 100 bp to 500 bp DNA fragments. After DNA underwent end repairing, phosphorylating, and A-tailing with Paired-End DNA Sample Prep kit (Illumina, San Diego, CA, USA), it was ligated to Illumina sequencing primer adaptors. Double-stranded DNA was then denatured and immunoprecipitated by anti-5-methylcytosine mouse monoclonal antibody (Calbiochem). The following procedure was the same as in the method described by Hu \[[@B6]\]. Briefly, after 220 bp to 320 bp bands were excised from the gel and purified, the products were quantified on Agilent 2100 Analyzer (Agilent Technologies, Santa Clara, CA, USA) and qPCR qualification, and DNA libraries were sequenced on the Illumina Hiseq 2000 (Illumina) by the Beijing Genomics Institute (BGI, Shenzhen, China).

Bioinformatic analysis
----------------------

Bioinformatic analysis was conducted according to a previously described protocol \[[@B6]\]. After the low-quality reads and those containing adapter reads were filtered, the MeDIP-seq data from Illumina sequencing were aligned to the UCSC cattle reference genome \[[@B50]\] (<http://hgdownload.cse.ucsc.edu/goldenPath/bosTau6/bigZips/bosTau6.fa.gz>) with SOAPaligner v 2.21 (<http://soap.genomics.org.cn/>) with no more than 2 bp mismatches. We analyzed the genome coverage of the CG, CHG, and CHH sites under different sequencing depths, distributions of MeDIP-Seq reads in different CG density regions, and the read distribution analysis including the distribution in cattle chromosomes and in the different genome components. The region from TSS to transcript end site was defined as the gene body region. The DNA methylation profile in the gene region was calculated by the reads that were aligned to a unique locus the genome.

Genome-wide highly methylated region (methylation peak, regions with sequencing tags more than 20, and a p value \< 1 x 10^−5^) scanning was conducted with MACS V 1.4.2 (<http://liulab.dfci.harvard.edu/MACS/>) \[[@B51]\]. The distribution of CpG in HMRs and the HMR distribution in the different components of the cattle genome (upstream 2 kb, 5′ UTR, CDS, intron, 3′ UTR, downstream 2 kb) were analyzed in our study.

CpGPlot (<https://gcg.gwdg.de/emboss/cpgplot.html>) was used to scan CpG islands (CGIs) with the following criteria: length \> 200 bp, GC content \> 50%, and observed-to-expected CpG ratio \> 0.6. CpG islands that overlapped with the HMRs were considered methylated. Genes that overlapped with the HMRs in promoter or gene body regions were considered methylated genes.

Bisulfite sequencing PCR analysis
---------------------------------

Nine gene regions were chosen to validate MeDIP-seq data with bisulfite PCR using unpooled individual samples. There were three individual samples in SCNT and control groups, respectively. First, with the use of the EZ DNA Methylation-Gold^™^ Kit (Zymo Research, Orange, CA, USA), the individual DNA samples were subjected to sodium bisulfite treatment as previously described \[[@B7]\]. After 20 μL DNA sample (500 ng to 900 ng) were added to the 130 μL CT Conversion Reagent in a PCR tube, the sample tubes were placed in a thermal cycle for 10 min at 95°C for DNA denaturation and 2.5 h at 64°C for bisulfite conversion. Modified DNA was desalted, purified, and finally eluted with 15 μL elution buffer. Subsequently, bisulfite sequencing PCR (BS-PCR) was immediately performed with a 2 μL modified DNA per PCR run. *CPT1B* in 5′ terminal region (4 kb) and upstream 2 kb of *IGF2*, *TCF7*, *HSP90AA1*, *UBE2S*, *SENP1*, *ZNF3*, *USP10*, and *CD44* were analyzed by MethPrimer software to predict the CpG islands \[[@B52]\]. The specific primers for BS-PCR were designed with MethPrimer software and Methyl Primer Express® Software v1.0 (Applied Biosystems Inc., Foster City, CA, USA) (Additional file [17](#S17){ref-type="supplementary-material"}). The Hot Start DNA polymerase Zymo Taq premix (Zymo Research) was used in BS-PCR. BS-PCR was performed in 50 μL reaction mixtures that contain 25 μL Zymo Taq premix, 2 μL modified DNA, 21 μL dH~2~O and 1 μL of both forward and reverse primers with the following program: 95°C for 10 min, followed by 40 cycles of denaturation at 95°C for 30 s, annealing at different temperatures (Additional file [17](#S17){ref-type="supplementary-material"}) for 30 s, extension at 72°C for 30 s, and a final extension at 72°C for 7 min. PCR products were gel-purified with TIANgel Midi Purification Kit (Tiangen). Purified fragments were subcloned into pMD20-T vectors (TaKaRa). For each individual sample, about 10 clones were selected for DNA sequencing (BGI). BIQ Analyzer software \[[@B53]\] was used to analyze bisulfite sequencing data and C--T conversion rates. Methylation data from bisulfite sequencing were analyzed by computation of the percentage of methylated CpGs of the total number of CpGs. The DNA methylation status of nine gene regions were compared between SCNT and control groups. Outcomes were tested by one-way ANOVA and LSD tests using the SPSS 16.0 software (SPSS Inc., Chicago, IL, USA). Differences were considered significant at P \< 0.05.

RNA-seq
-------

Total RNA from bovine placentas was extracted with TRIZOL reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Total placental RNAs were extracted from the same placentas as in MeDIP-seq analysis. Total RNA at 30 microgram for each sample (SCNT and control) was treated with RNase-Free DNase I (NEB, UK) for 15 min at 37°C to remove DNA contamination. Agilent 2100 was used to assess the concentration and quality of RNA. Total RNA at 2 microgram from each sample was used in library construction, respectively. The mRNAs were enriched with the oligo (dT) magnetic beads. After the mRNAs were broken into short fragments (about 200 bp) with the fragmentation buffer, the first strand cDNA was synthesized by random hexamer-primer with the mRNA fragments as templates. Buffer, dNTPs, RNase H, and DNA polymerase I were added to synthesize the second strand. The double strand cDNA was purified with QiaQuick PCR extraction kit (Qiagen) and washed with elution buffer for end repair and single nucleotide "A" addition. After the sequencing adaptors were ligated to the fragments, the required fragments were purified by agarose gel electrophoresis and enriched by PCR amplification. Finally, the library products were used for sequencing analysis with Illumina HiSeq™ 2000. The sequences obtained were mapped to the RefSeq database. Sequences uniquely mapped to the RefSeq genes were used for subsequent analysis. The gene expression level was calculated with reads per kb per million (RPKM) reads method, and the formula used was as follows:

$$\mathit{RPKM} = \frac{10^{6}C}{\left. \mathit{NL}/10^{3} \right.}$$

where RPKM(A) is considered as the expression of gene A, C is the number of reads that uniquely aligned to gene A, N is the total number of reads that uniquely aligned to all genes, and L is the number of bases in gene A.
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**Genome coverage of the CG, CHG, and CHH sites under different sequencing depth.** The horizontal axis represents reads depth, whereas the vertical axis represents the percentage of genome coverage of the CG (A and B), CHG (C and D), and CHH (E and F) sites at a relative read depth. SCNT (A, C, and E) and control (B, D, and F) placentas.
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Distribution of MeDIP-Seq reads in different CG density regions. (A): SCNT placenta; (B): control placenta.
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**Genomic distribution of the uniquely mapped reads.** The additional file shows the genomic distribution of the uniquely mapped reads in the SCNT and control placentas.
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Highly methylated regions in the bovine SCNT-placenta.
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Highly methylated regions in the bovine control-placenta.

###### 

Click here for file

###### Additional file 6

**CpG number in HMRs.(A):** SCNT placenta; **(B):** control placenta.
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**HMR genome coverage in different components of the genome.(A):** SCNT placenta; **(B):** control placenta.
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CpG islands in the bovine placenta.
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Methylated CpG islands in bovine SCNT-placenta.
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Methylated CpG islands in bovine control-placenta.
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Methylated genes in bovine SCNT-placenta.
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Methylated genes in the bovine control-placenta.
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**Validation of MeDIP-seq data by bisulfite sequencing.** Nine gene regions were chosen to validate MeDIP-seq data.
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Gene expression level analyzed by RNA-seq.
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Gene list at various expression levels.
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Pipeline of library construction for MeDIP-seq.
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Primer sequences for BS--PCR.
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